This year, the UN High-Level Political Forum convened virtually, and ReAct and South Centre co-organized a side-event panel discussion on “Ensuring a Sustainable and Resilient Response to COVID-19 and Emerging Infectious Diseases through Local Production.” Here are a few key points and you find a recording of the webinar further down in this article.
For the panel, speakers that are familiar with local production of medicines and vaccines in low- and middle-income countries spoke to:
- the opportunities for expanding local production
- harnessing pooled procurement and
- the challenges ahead and how they might be met.
The UN High-Level Political Forum (HLPF) is the United Nation’s central platform for monitoring progress on the 2030 Agenda for Sustainable Development and the Sustainable Development Goals. For the 4th UN High-Level Political Forum, the theme was the “Sustainable and resilient recovery from the COVID-19 pandemic”.
Professor Anthony So, Director of ReAct North America, shared a policy overview and the challenges for establishing local manufacturing. In his comments, he highlighted the need for public sector collective action, much like the world once saw with the scale-up of penicillin during World War II.
Regarding the historic decision by UNICEF/WHO and the Indian government to build local penicillin manufacturing back in the 1950s:
“Perhaps some history is worth repeating.”
said Professor Anthony So
Challenges and opportunities for bringing vaccine production to Africa
For the main panel, Ayoade “Yodi” Olatunbosun-Alakija from the African Union’s Africa Vaccine Delivery Alliance for COVID-19 and Patrick Tippoo with the African Vaccine Manufacturing Initiative (AVMI) and Biovac spoke to the challenges and opportunities for bringing vaccine production to the African context.
Ms. Olatunbosun-Alakija’s remarks reflected on the need to put the building blocks in place now and that the issue is multi-sectoral. As a result, Ministers of Finance and Trade must come aboard to make vaccine production in low- and middle-income countries a global good.
Shape market in Africa
In a similar vein, Mr Tippo said that the easiest way to guarantee access is to make the product yourself. To enable this, it will be necessary to shape the market in Africa. However, the African context is not starting from ground zero, there are already five active African vaccine manufacturers.
Dr Akira Homma with Fiocruz’ Bio-Manguinhos program talked about Brazil’s lessons on local production. These efforts must be sustainable technologically and economically. Furthermore, Brazil has benefited from public-private partnerships for speeding up production activity.
Latin American region depend on imported health technology
After the main panel, Dr Analía Porrás (PAHO) and Jean-Michel Piedagnel (Drugs for Neglected Diseases Initiative) provided further comments. Dr Porrás highlighted the dependencies of the Latin American region on imported health technologies. At the start of the pandemic, the region had to rely on imports for critical health technologies, with only 4% originating from the region.
See recording of the ReAct and South Center webinar: “Ensuring a Sustainable and Resilient Response to COVID-19 and Emerging Infectious Diseases through Local Production”.
More news and opinion
- 5 years after the UN Political Declaration on AMR – where are we now?
- Víctor Orellana
- Local production of vaccines and medicines in focus: Key points from ReAct and South Center UN HLPF side-event
- Behavior change to manage antimicrobial resistance: 8 briefs and 1 webinar-launch by Uppsala Health Summit
- ReAct and ICARS to develop policy guides and tools for low resource settings
- Tapiwa Kujinga, Director of PATAM: In Zimbabwe civil society is involved in every aspect of the response to AMR
- COVID-19: India pays a high price for indiscriminate drug use
- Lancet Global Health article release: Resetting the agenda for antibiotic resistance
- 3 key takeaways for AMR from this year’s World Health Assembly WHA74
- Antibiotic resistance – far more than a medical problem
- UN High-level Dialogue on AMR: political will and investments needed
- Resetting the agenda for antibiotic resistance through a health systems perspective
- 3 questions to newly appointed STAG-AMR members Otridah Kapona and Sujith Chandy
- Walk the talk: time is ticking for all to act on antibiotic resistance!
- Vanessa Carter: 3 years of surviving a drug-resistant infection made me want to create change
- Upcoming ReAct Webinar: Expert Conversation about new report
- New ReAct report: Governments need to take more leadership to ensure global sustainable access to effective antibiotics
- 4 considerations for addressing antimicrobial resistance through pandemic preparedness
- Preventing the next pandemic: Addressing antibiotic resistance
- 4 key takeaways from the virtual ReAct Africa Conference 2020
- The threat of the unknown: is lack of global burden data slowing down work on antibiotic resistance?
- ReAct input to the WHO Executive Board Session on Antimicrobial Resistance
- Dr Gautham: informal health providers key to reducing antibiotic use in rural India